Iranian Society of Gynecology Oncology

Document Type : Original Research Article


1 Research Team in Congenital Anomalies, Training in Clinical Epidemiology and Medical-Surgical Sciences, Faculty of Medicine and Pharmacy Rabat-University Mohammed V, Rabat, Morocco

2 Intensive Care Anaesthesia Department, Faculty of Medicine and Pharmacy, CHU Souss Massa, Ibn Zohr University, Agadir, Morocco

3 Centre for External Consultations and Explorations, Children's Hospital, Centre Hospitalier Universitaire IBN SINA, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco


Background & Objective: The safety of women during childbirth and personnel working in maternity care amidst the COVID-19 pandemic is a priority for the health system. Hence, good risk management practices need to be implemented to reduce the spread of infection between healthcare workers and pregnant women who have contracted COVID-19. Therefore, this study aimed to establish a risk map for managing dyspneic parturients suffering from COVID-19-related pneumopathy during delivery.
Materials & Methods: This study focuses on examining potential risks beforehand in the context of the management of a dyspneic parturient suffering from COVID-19-related pneumopathy during delivery, executed using the method FMECA (Failure Mode, Effects and Criticality Analysis); this was conducted from September to December 2021 in the maternity service of the Hospital Center ElJadida, Morocco.
Results: The risk analysis of a dyspneic parturient suffering from COVID-19-related pneumopathy during delivery revealed thirteen failure modes. Proposed are corrective measures aimed at addressing the failure modes of criticality class C3 whose vital risks are linked to the care of the dyspneic parturient suffering from COVID-19-related pneumopathy at the level of the reanimation service and the level of the neonatal intensive care unit.
Conclusion: Employing risk mapping is a fundamental instrument for the ongoing enhancement of quality to maximize the safety of the parturient care process by changing the organizational culture from a reactive to a preventive approach.


 Employing risk mapping is a fundamental instrument for the ongoing enhancement of quality to maximize the safety of the parturient care process by changing the organizational culture from a reactive to a preventive approach.


Main Subjects

1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. New Eng J Med. 2020;382(8):727-33. [DOI:10.1056/NEJMoa2001017] [PMID] [PMCID]
2. Majumder J, Minko T. Recent developments on therapeutic and diagnostic approaches for COVID-19. AAPS J. 2021;23:1-22. [DOI:10.1208/s12248-020-00532-2] [PMID] [PMCID]
3. Razavi D, Noorulhuda M, Velez M, Kapiriri L, Collaboration G. The role of priority setting in pandemic preparedness and response: a comparative analysis of COVID-19 pandemic plans in 12 countries in the Eastern Mediterranean region. Health Policy OPEN. 2022;3:100084. [DOI:10.1016/j.hpopen.2022.100084] [PMID] [PMCID]
4. Ahizoune S, Alaoui AM, Belrhiti Z. La résilience des hôpitaux pendant Covid-19 : une seule étude de cas à méthodes mixtes au Maroc. Kinésithérapie, la Revue. 2023;23(258):3-10. [DOI:10.1016/j.kine.2022.09.007] [PMCID]
5. Semenova Y, Pivina L, Khismetova Z, Auyezova A, Nurbakyt A, Kauysheva A, et al. Anticipating the Need for Healthcare Resources Following the Escalation of the COVID-19 Outbreak in the Republic of Kazakhstan. J Prev Med Public Health. 2020;53(6):387-96. [DOI:10.3961/jpmph.20.395] [PMID] [PMCID]
6. Organisation et prise en charge de la grossesse. de l'accouchement et du post-partum durant la période de pandémie COVID-19. 2020.
7. Parag Goyal JJC. C or re sp ondence Clinical Characteristics of Covid-19 in China. Clinical Characteristics of Covid-19 in China2020. p. 1-3.
8. Ellington S, Strid P, Tong VT, Woodworth K, Galang RR, Zambrano LD, et al. Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-June 7, 2020. Morb Mortal Wkly Rep. 2020;69(25):769-75. [DOI:10.15585/mmwr.mm6925a1] [PMID] [PMCID]
9. Schwartz DA. Being pregnant during the Kivu Ebola virus outbreak in DR Congo: the rVSV-ZEBOV vaccine and its accessibility by mothers and infants during humanitarian crises and in conflict areas. Vaccines. 2020;8(1):38. [DOI:10.3390/vaccines8010038] [PMID] [PMCID]
10. Kazemi Aski S, Alizadeh S, Ghafourian Abadi S, Yaseri Gilvaei F, Kiai SM. Awareness of Coronavirus Disease and Perceived Stress in Pregnant Women. J Obstet Gynecol Cancer Res. 2022;7(3):235-42. [DOI:10.30699/jogcr.7.3.235]
11. Yang R, Mei H, Zheng T, Fu Q, Zhang Y, Buka S, et al. Pregnant women with COVID-19 and risk of adverse birth outcomes and maternal-fetal vertical transmission: a population-based cohort study in Wuhan, China. BMC Med. 2020;18(1):1-7. [DOI:10.1186/s12916-020-01798-1] [PMID] [PMCID]
12. Mendoza M, Garcia-Ruiz I, Maiz N, Rodo C, Garcia-Manau P, Serrano B, et al. Pre-eclampsia-like syndrome induced by severe COVID-19: a prospective observational study. Int J Obstet Gynaecol. 2020;127(11):1374-80. [DOI:10.1111/1471-0528.16339] [PMID] [PMCID]
13. Di Mascio D, Khalil A, Saccone G, Rizzo G, Buca D, Liberati M, et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2020;2(2):100107. [DOI:10.1016/j.ajogmf.2020.100107] [PMID] [PMCID]
14. Morau E, Bouvet L, Dewandre PY, Vial F, Bonnin M, Chassard D, et al. COVID-19, pregnancy, anaesthesia and intensive care: Report and prospect. Prat Anesth Reanim. 2022;26(2):63-6.
15. Peyronnet V, Sibiude J, Deruelle P, Huissoud C, Lescure X, Lucet JC, et al. Infection par le SARS-CoV-2 chez les femmes enceintes : état des connaissances et proposition de prise en charge par CNGOF. Gynecol Obstet Fertil Senol. 2020;48(5):436-43. [DOI:10.1016/j.gofs.2020.03.014] [DOI:10.1016/j.gofs.2020.10.001]
16. Goyal M, Singh P, Melana N. Review of care and management of pregnant women during COVID-19 pandemic. Taiwan J Obstet Gynecol. 2020;59(6):791-4. [DOI:10.1016/j.tjog.2020.09.001] [PMID] [PMCID]
17. Ung N, Bonnet MP. Obstetric anaesthesia during the COVID-19 pandemic. Prat Anesth Reanim. 2020;24(4):196-201. [DOI:10.1016/j.pratan.2020.07.005] [PMID] [PMCID]
18. El Hiyani M, Ahizoune S, Mdaghri Alaoui A, Thimou Izgua A. Factors Associated with Neonatal Mortality in the Neonatology Department of the Regional Hospital Center, AGADIR, MOROCCO. Iran J Neonatol. 2023;14(1):18-25.
19. Kumar R, Meurah C, Asri N, Masand R. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19. 2020.
20. Poon LC, Yang H, Lee JCS, Copel JA, Leung TY, Zhang Y, et al. ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals. Ultrasound Obstet Gynecol. 2020;55(5):700-8. [DOI:10.1002/uog.22013] [PMID] [PMCID]
21. Lipol LS, Haq J. Risk analysis method: FMEA/FMECA in the organizations. Int j Basic Appl Sci. 2011;11(5):74-82.
22. Glowicz J, Benowitz I, Arduino MJ, Li R, Wu K, Jordan A, et al. Keeping health care linens clean: Underrecognized hazards and critical control points to avoid contamination of laundered health care textiles. Am J Infect Control. 2022;50(10):1178-81. [DOI:10.1016/j.ajic.2022.06.026] [PMID] [PMCID]
23. Müller MM, Baillès E, Blanch J, Torres X, Rousaud A, Cañizares S, et al. Burnout among hospital staff during the COVID-19 pandemic: Longitudinal results from the international Cope-Corona survey study. J Psychosom Res. 2023;164:111102. [DOI:10.1016/j.jpsychores.2022.111102] [PMID] [PMCID]
24. Rousseau A, Dubel-Jam M, Schantz C, Gaucher L. Barrier measures implemented in French maternity hospitals during the COVID-19 pandemic: A cross-sectional survey. Midwifery. 2023;118:103600. [DOI:10.1016/j.midw.2023.103600] [PMID] [PMCID]
25. Chan C, Kong J, Babata K, Mazzarella K, Adhikari E, Yeo K. Optimal delivery management for the prevention of early neonatal SARS-CoV-2 infection. 2021. [DOI:10.1002/14651858.CD013689.pub2] [PMCID]
26. Hascoët JM. [Adaptation of Health Care Organization in a level III Maternity Hospital during the COVID-19 pandemic]. Bull Acad Natl Med. 2021;205(8):981-4.
27. Vial F, Mortier L, Rouche J, de Malartic CM, Herbain D, Gauchotte E, et al. Feedback on COVID-19 outbreak in a French tertiary maternity. Ann Fr Med Urgence. 2020;10(4):251-60. [DOI:10.3166/afmu-2020-0271]
28. Sezen GY, Ersoy Ö, Yorulmaz İS, İSkender A. Experıences Of Duzce Unıversıty Department Of Anesthesıology And Reanımatıon In Covid-19 Pandemıc. Konuralp Med J. 2020;12(S1):364-8. [DOI:10.18521/ktd.758026]
29. San-Juan R, Barbero P, Fernandez-Ruiz M, Lopez-Medrano F, Lizasoain M, Hernandez-Jimenez P, et al. Incidence and clinical profiles of COVID-19 pneumonia in pregnant women: A single-centre cohort study from Spain. EClinicalMedicine. 2020;23:100407. [DOI:10.1016/j.eclinm.2020.100407] [PMID] [PMCID]
30. Kayem G, Lecarpentier E, Deruelle P, Bretelle F, Azria E, Blanc J, et al. A snapshot of the Covid-19 pandemic among pregnant women in France. J Gynecol Obstet Hum Reprod. 2020;49(7):101826. [DOI:10.1016/j.jogoh.2020.101826] [PMID] [PMCID]